Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] |
The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands): | | | | | | | | | | | | | | | | | | | | | | | Derivatives Designated as Cash Flow Hedging Instruments | | | Condensed Consolidated Balance Sheet Location | | Foreign Exchange Contracts | | Interest Rate Swaps | | Gross Derivatives | | | | | | | | As of March 31, 2025 | | | | | | | Prepaid expenses and other current assets | | $ | 3,560 | | | $ | 8,403 | | | $ | 11,963 | | Other assets | | — | | | 512 | | | 512 | | Total assets | | $ | 3,560 | | | $ | 8,915 | | | $ | 12,475 | | | | | | | | | Accrued liabilities | | $ | 4,335 | | | $ | — | | | $ | 4,335 | | | | | | | | | Total liabilities | | $ | 4,335 | | | $ | — | | | $ | 4,335 | | | | | | | | | As of December 31, 2024 | | | | | | | Prepaid expenses and other current assets | | $ | 6,716 | | | $ | 11,038 | | | $ | 17,754 | | Other assets | | — | | | 5,724 | | | 5,724 | | Total assets | | $ | 6,716 | | | $ | 16,762 | | | $ | 23,478 | | | | | | | | | Accrued liabilities | | $ | 7,391 | | | $ | — | | | $ | 7,391 | | | | | | | | | Total liabilities | | $ | 7,391 | | | $ | — | | | $ | 7,391 | |
We recognized the following (losses) gains on our derivative instruments designated as cash flow hedges in other comprehensive income before reclassifications to net loss (in thousands): | | | | | | | | | | | | | | | | | | | | | (Losses) Gains Recognized in Other Comprehensive Income (Loss) | | | Three months ended March 31, | | | | | 2025 | | 2024 | | | | | Derivatives designated as cash flow hedging instruments: | | | | | | | | | Foreign exchange forward contracts | | $ | (174) | | | $ | 4,940 | | | | | | Interest rate swaps | | (4,091) | | | 13,393 | | | | | | Total derivatives designated as cash flow hedging instruments | | $ | (4,265) | | | $ | 18,333 | | | | | |
The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):
|
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Gains (Losses) Reclassified From Accumulated Other Comprehensive Income (Loss) into Income | | | | | Three months ended March 31, | | | | | Location of Gains (Losses) Recognized in Net Loss | | 2025 | | 2024 | | | | | Derivatives designated as cash flow hedging instruments: | | | | | | | | | | | Foreign exchange forward contracts | | Total revenues | | $ | 709 | | | $ | 700 | | | | | | Foreign exchange forward contracts | | Cost of goods sold | | (1,014) | | | 1,280 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Interest rate swaps | | Interest expense | | 3,756 | | | 7,964 | | | | | | Total derivatives designated as cash flow hedging instruments | | | | $ | 3,451 | | | $ | 9,944 | | | | | |
As of March 31, 2025, we expect an estimated $0.8 million in deferred losses on the outstanding foreign exchange contracts and an estimated $8.4 million in deferred gains on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.
|